The results validated and predicted the molecular mechanism of CKI in LC at a system level, which might provide insight into the mechanisms of CKI and other anticancer TCMs and facilitate the widespread application of CKI in treating LC. The gene discussed is CHKA; the disease is laryngotracheoesophageal cleft.